hydroxyl radical has been researched along with am 36 in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (am 36) | Trials (am 36) | Recent Studies (post-2010) (am 36) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 12 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaway, JK; Jarrott, B; Lawrence, AJ | 1 |
1 other study(ies) available for hydroxyl radical and am 36
| Article | Year |
|---|---|
AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Brain; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Endothelin-1; Hydroxyl Radical; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Male; Microdialysis; Neuroprotective Agents; Piperazines; Rats; Rats, Long-Evans; Reactive Oxygen Species; Time Factors; Treatment Outcome | 2003 |